Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 5/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.39 |
| ▸ | GBA1 | P04062 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.34 |
| ▸ | CLK4 | Q9HAZ1 | 3/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 4/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19106199 | 0.94 | CYP11B1 (0.48) | CYP11B1GPR84GBA1KMT2ACYP11B2 | |
| SCHEMBL19106253 | 0.86 | CYP11B1 (0.51) | CYP11B1GPR84GBA1KMT2ACYP11B2 | |
| SCHEMBL19106205 | 0.86 | MEN1 (0.39) | CYP11B1KMT2AALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL16581220 | 0.85 | CYP11B1 (0.52) | CYP11B1GPR84GBA1KMT2ACYP11B2 | |
| SCHEMBL16581296 | 0.85 | CYP11B1 (0.49) | CYP11B1GPR84GBA1KMT2ACYP11B2 | |
| SCHEMBL19106303 | 0.84 | CYP11B1 (0.51) | CYP11B1GPR84GBA1KMT2ACYP11B2 | |
| SCHEMBL19106280 | 0.81 | CYP11B1 (0.52) | CYP11B1GPR84GBA1CYP11B2ALDH1A1 | |
| SCHEMBL16581201 | 0.81 | CYP11B1 (0.38) | CYP11B1GPR84GBA1KMT2ACYP11B2 | |
| SCHEMBL19106353 | 0.80 | CYP11B1 (0.37) | CYP11B1KMT2AALDH1A1MEN1MAPT | |
| SCHEMBL16581110 | 0.80 | CYP11B1 (0.39) | CYP11B1KMT2AALDH1A1MEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10734588-B2 | Compound for organic electronic element, and organic electronic element and electronic device using same | DUK SAN NEOLUX CO., LTD (KR) | 2020-08-04 | — | — | US | disclosed |
| US-20170200903-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | DUK SAN NEOLUX CO., LTD. (KR) | 2017-07-13 | — | — | US | disclosed |
| US-20170200903-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | DUK SAN NEOLUX CO., LTD. (KR) | 2017-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170200903-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | NFE2L2, ESR1, VDAC2 | CYP11B1 1948/4885GPR84 4240/4885GBA1 2489/4885 |
| US-10734588-B2 | Compound for organic electronic element, and organic electronic element and electronic device using same | NFE2L2, ESR1, VDAC2 | CYP11B1 1948/4885GPR84 4240/4885GBA1 2489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.